600774.SH
Hanshang Group Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 7.10
+0.85%Oct 28, 2026, 09:48 UTC
H&S Group reported third-quarter 2026 revenue of 215 million yuan, down 14.40% year over year, and a net loss of 4.5688 million yuan, compared with a profit a year earlier; for the first nine months, revenue was 676 million yuan, down 11.47%, and net loss was 463,400 yuan, compared with a profit a year earlier.
Source:Sep 1, 2026, 09:57 UTC
Hangzhou Han Group announced it will cancel 6,024,130 repurchased shares and reduce its registered capital, effective September 2, 2026.
Source:Aug 30, 2026, 07:35 UTC
Hanshang Group announced its unaudited first-half 2026 results: main business revenue of 461 million yuan, down 10.03% year-on-year, with gross margin of 43.28%, down 3.33 percentage points.